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Abstract
Background—The effectiveness of low-fat diets for long-term weight loss has been debated for 
decades, with dozens of randomized trials (RCTs) and recent reviews giving mixed results.
Methods—We conducted a random effects meta-analysis of RCTs to estimate the long-term 
effect of low-fat vs. higher fat dietary interventions on weight loss. Our search included RCTs 
conducted in adult populations reporting weight change outcomes at ≥1 year, comparing low-fat 
with higher fat interventions, published through July 2014. The primary outcome measure was 
mean difference in weight change between interventions.
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Findings—Fifty-three studies met inclusion criteria representing 68,128 participants. In the 
setting of weight loss trials, low-carbohydrate interventions led to significantly greater weight loss 
than low-fat interventions (n comparisons=18; weighted mean difference [WMD]=1.15 kg, 95% 
CI=0.52 to 1.79; I2=10%). Low-fat did not lead to differences in weight change compared with 
other moderate fat weight loss interventions (n=19; WMD=0.36, 95% CI=-0.66 to 1.37; I2=82%), 
and were superior only when compared with “usual diet” (n=8; WMD=-5.41, 95% CI=-7.29 to 
−3.54; I2=68%). Similarly, non-weight loss trials and weight maintenance trials, for which there 
were no low-carbohydrate comparisons, had similar effects for low-fat vs moderate fat 
interventions, and were superior compared with “usual diet”. Weight loss trials achieving a greater 
difference in fat intake at follow-up significantly favored the higher fat dietary interventions, as 
indicated by difference of ≥5% of calories from fat (n=18; WMD=1.04, 95% CI=0.06 to 2.03; 
I2=78%) or by difference in change serum triglycerides of ≥5 mg/dL (n=17; WMD=1.38, 95% 
CI=0.50 to 2.25; I2=62%).
Interpretation—These findings suggest that the long-term effect of low-fat diets on body weight 
depends on the intensity of intervention in the comparison group. When compared to dietary 
interventions of similar intensity, evidence from RCTs does not support low-fat diets over other 
dietary interventions.
Introduction
Identifying effective strategies for long-term weight control will be critical to reduce the 
alarming prevalence of overweight and obesity worldwide. The macronutrient composition 
of the diet, or the proportions of calories contributed by fat, carbohydrate, and protein, has 
received significant attention in past decades for its potential relevance in weight loss and 
weight maintenance. Numerous short- and long-term randomized trials across a variety of 
general and clinical populations have attempted to identify the optimal ratio of 
macronutrients for weight loss. Lowering the proportion of daily calories consumed from 
total fat has been targeted for many reasons, one of which is that a single gram of fat 
contains more than twice the calories of a gram of carbohydrates or protein (9 kcal/gram vs. 
4 kcal/gram). Thus, reducing total fat intake may theoretically lead to an appreciable impact 
on total calories consumed. However, randomized trials have failed to consistently 
demonstrate that reducing the percent of energy from total fat leads to long-term weight loss 
compared to other dietary interventions.
This systematic review and meta-analysis aimed to summarize the large body of evidence 
from randomized control trials (RCTs) lasting ≥1 year in which weight changes on low-fat 
diets vs. other dietary intervention groups were compared. Trials were included regardless of 
whether weight loss was intended or not, for example in studies evaluating lipids or cancer 
endpoints. We considered stratification by characteristics of the interventions that may affect 
differences in weight loss, including whether the intervention arms received similar attention 
and intervention intensity, or the composition of the comparison diet. We hypothesized that 
low-fat diets would not be associated with greater weight loss when differences in these 
intervention characteristics were taken into account, and that differences in weight loss 
favoring higher fat interventions would be larger when adherence was greater.
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Methods
Search strategy and inclusion criteria
Predefined search strategy, study eligibility criteria, and statistical methodological 
approaches, were detailed in our unpublished research protocol. Full details of our literature 
search (Page 2) and PRISMA checklist (Pages 7–10) are outlined in the Appendix. Briefly, 
we used the MEDLINE, EMBASE, CENTRAL, and Cochrane Database of Systematic 
Reviews to identify eligible trials. We included trials lasting ≥1 year comparing weight 
change on a low-fat diet (as defined by authors) with any higher fat dietary intervention, 
including “usual diet” among non-pregnant adults. Trials of shorter duration were excluded 
because weight-loss trials frequently observe an initial maximal weight loss around 6 
months with subsequent weight regain.
The outcome of interest was long-term (≥1 year) change in body weight (reported as mean 
change from baseline, mean change difference, or mean body weight at end of follow-up). 
Efforts were made to contact authors to obtain variance measures, if not reported, but were 
ultimately excluded if unavailable. We excluded trials if one intervention group included a 
non-dietary weight loss component (e.g., exercise regimen, pharmaceutical intervention) 
while the other did not. We did not make exclusions based on concomitant dietary 
components (e.g., increase fruits and vegetables). Nonrandomized trials were excluded as 
well as dietary supplements or meal replacement drink interventions as these were beyond 
the scope of our investigation. If trial results were published more than once, the paper with 
the most complete follow-up was included in the main analysis. Screening of abstracts for 
relevance was conducted by two reviewers (DT, MC) and eligible full texts were reviewed 
with an inclusion/exclusion criteria sheet independently and in duplicate by two reviewers 
(DT, MC).
Data extraction
Variables captured from the final accepted studies included study level information (authors, 
country, center), study population characteristics, intervention details, including weight loss 
intention (yes, no, maintain) and the relative intensity of each intervention, as described by 
study authors (i.e., systematically greater attention, time spent with study clinicians, 
dieticians, program materials, etc for one intervention group over the other), and outcomes 
by treatment arm. We also recorded dietary adherence, including change in serum 
triglyceride levels and the percent calories from fat during follow-up. We analyzed the 
intention-to-treat estimates, when reported.
We evaluated the trials’ potential for bias using the Cochrane risk of bias assessment tool.(1) 
Data were extracted independently by two investigators (DT, MC), and discrepancies 
resolved with a third reviewer (FH), if necessary.
Data analysis
We calculated the mean difference in body weight change from baseline by subtracting the 
mean change of the comparison diet group from the mean change in the low-fat diet group. 
If the mean change was not reported we compared the groups’ final mean body weights, 
Tobias et al. Page 3
Lancet Diabetes Endocrinol. Author manuscript; available in PMC 2016 December 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
under the assumption that randomization resulted in similar average baseline body weights 
between treatment arms. We estimated the pooled weighted mean difference and 95% 
confidence interval (CI) with a DerSimonian and Laird random effects model. P<0.05 was 
considered statistically significant.
We assessed heterogeneity from the Mantel-Haenszel model and I2 values (the percent of 
variance in the pooled estimate due to between-study differences), with I2>50% indicating 
moderate heterogeneity.(2) Analyses established a priori were conducted to evaluate 
potential heterogeneity by the whether the trial was designed with the intention of weight 
loss, the composition of the comparison diet (low-carbohydrate, other moderate 
fat/”healthful” diet, or usual diet), the interventions’ relative intensity, , whether either, 
neither, or both of the interventions included caloric restriction, and the baseline health 
status of the participants. Additionally, we stratified by change in triglyceride levels and in 
attained self-reported percent calories from fat, with an increase in triglycerides reflecting a 
relative decrease in fat intake.(3)
Finally, we conducted sensitivity analyses to assess the robustness of findings. We evaluated 
the impact of removing the largest study or studies, based on their percent weight in the 
pooled estimates and restricted to trials conducting intention-to-treat analyses and with ≥100 
participants. Primary analyses were repeated using an inverse variance weighted fixed effect 
model. The Begg (4) and Egger (5, 6) tests were conducted to test for the potential of 
publication bias by plotting the inverse of the variance against the treatment effect. Analyses 
were performed using STATA® version 13.1.
Role of the funding source
The funding sources did not participate in the design or conduct of the study; collection, 
management, analysis or interpretation of the data; preparation, review, or approval of the 
manuscript. DT had full access to all of the data and the final responsibility to submit for 
publication.
RESULTS
Our search yielded 3,517 citations (Figure 1), of which 53 RCTs were eligible for inclusion 
in our analysis (Table 1). The majority of trials were conducted in North America (n=37) 
and were 1 year in duration (n=27). Twenty trials specifically enrolled participants with 
prevalent chronic diseases, including breast cancer,(7–10) hypercholesterolemia,(11–13) and 
type 2 diabetes.(14–22) In addition to 35 weight loss trials, there were 13 trials with no 
intended intervention on weight, (7–10, 12, 13, 22–28) and 5 weight maintenance trials 
designed to maintain baseline body weight. (11, 29–32)
The low-fat dietary interventions ranged from very low-fat ≤10% of calories from fat, to 
more moderate goals of ≤30% of calories from fat. Comparator diets of higher fat intake 
were diverse, ranging from a single baseline interaction with instructions to maintain “usual 
diet”, to a variety of other dietary interventions, including low-carbohydrate and other 
moderate-to-high-fat diets. The intensity of the interventions varied from pamphlets or 
instructions given at baseline only, to multicomponent programs integrating counseling 
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sessions, regular meetings with dieticians, food diaries, cooking lessons, etc., to feeding 
studies, in which participants were given a significant portion of their food. Caloric 
restriction was a component of many weight loss interventions, but not all. For example, 
despite being a weight loss intervention, a low-carbohydrate Atkins-style diet is often ad 
libitum (i.e., eat until satiated).
Our primary meta-analysis included 68,128 adults from eligible randomized clinical trials, 
reporting a mean weight loss of 2.71 kg (SD=2.8) after a median of 1 year of follow-up, and 
3.75 kg (SD=2.7) among weight loss trials. Figure 2 presents the overall results according to 
weight loss trial design (yes, no, or maintain) and composition of comparator intervention 
(low-carbohydrate, other higher fat intervention, or usual diet). No difference between low-
fat and higher fat dietary interventions was observed when all weight loss trials were 
combined, although there was significant between-study heterogeneity. Low-carbohydrate 
weight loss interventions led to an average 1.15 kg greater long-term weight loss than low-
fat weight loss interventions, with minimal between-study heterogeneity. No difference, 
however, was observed between low-fat and other higher fat dietary interventions. 
Compared with groups only following their usual diet, low-fat weight loss interventions led 
to 5.41 kg greater weight loss. Non-weight loss trials and weight maintenance trials also 
found a significant but smaller magnitude of weight loss in low-fat interventions when 
compared with usual diet, and no difference between low-fat and other higher fat dietary 
interventions. No long-term non-weight loss or weight maintenance trials compared low-fat 
with low-carbohydrate dietary interventions.
Table 2 presents analyses stratified by additional trial characteristics, limited to trials of 
similar intensity to minimize bias from one group receiving more attention and higher 
intervention intensity. Only 4 of the 17 comparisons among trials without a weight loss goal 
(13, 22, 24) and 1 of the 6 comparisons among weight maintenance trials (31) remained, 
limiting our ability to stratify further; thus, Table 2 includes weight loss trials only, which 
trended towards greater weight loss for higher fat interventions. Stratifying by caloric 
restriction indicated no significant difference in weight loss between low-fat and higher fat 
dietary weight loss interventions when interventions were concordant for caloric restriction. 
Calorie-restricted low-fat diets, however, fared significantly worse compared with non-
calorie restricted higher fat interventions. Results were similar for weight loss trials among 
participants with or without a specific chronic disease at baseline (e.g., breast cancer).
When groups differed by >5% calories from fat at follow-up, higher fat led to significantly 
greater weight loss than low-fat weight loss interventions. Similarly, weight loss trials with a 
≥5 mg/dL greater change in triglycerides for low-fat vs. higher fat interventions, led to 
significantly greater weight loss for the higher fat groups.
Excluding the Women’s Health Initiative trial (96.90% of weight) from weight maintenance 
trials, did not impact findings (n=5; WMD=-0.77 kg, 95% CI=-1.50 to −0.04, p=0.039; 
I2=0.0%, p-heterogeneity=0.95). Results were similar when restricted studies conducting to 
intention-to-treat analyses (Appendix pages 3–4) and when excluding smaller trials of <100 
total participants, although few non-weight loss or weight maintenance trials remained 
eligible according to these criteria. The fixed effect meta-analysis (Appendix pages 5–6), 
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which gives less weight to smaller trials with greater variance, estimated 0.44 kg greater 
weight loss for the comparator vs. low-fat interventions among the weight loss trials. Fixed 
effect analyses stratified by comparator group also indicated greater weight loss for “other 
higher fat interventions” vs. low-fat in trials with and without a weight loss goal, which 
showed no difference in the random effects analysis.
Results from the Cochrane risk of bias assessment tool (Appendix pages 10–12) were 
variable and evaluation was limited for many studies by a lack of reporting. Incomplete 
outcome data was a high potential source of bias for 39 trials due to dropout and lost-to-
follow-up rates exceeding 5%. Differential intervention intensity was deemed a source of 
bias for 20 trials. Both the Begg and Egger’s tests for small-study effects did not indicate 
publication bias (p=0.83 and p=0.85, respectively). Visual inspection of the funnel plot 
demonstrated an approximately symmetrical distribution of the inverse variances, which is 
consistent with these findings (Appendix page 13).
Discussion
Results from this comprehensive meta-analysis of RCTs with at least 1 year of follow-up 
indicate low-fat dietary interventions do not lead to greater weight loss when compared with 
higher fat dietary interventions of similar intensity, regardless of the weight loss intention of 
the trial. In fact, in the setting of weight loss trials, higher fat, low-carbohydrate dietary 
interventions led to a modest but significant greater long-term weight loss than low-fat 
interventions. Other higher fat dietary interventions led to similar weight loss as the low-fat 
groups, whether the trial had a weight loss goal or not. Low-fat interventions were favored 
only in comparison with interventions of lesser intensity, particularly those in which controls 
were only asked to maintain their usual diet. Furthermore, trials achieving greater 
differences in dietary fat intake and serum triglyceride concentrations resulted in greater 
weight loss under the higher fat interventions. Although these are not perfect measures of 
dietary fat intake, given the potential for measurement error in self-reported diet and 
confounding by weight loss for triglycerides as a marker of fat intake, results were 
consistent between these two methods.
This systematic literature review and meta-analysis highlights several important points. 
First, of the 53 eligible RCTs, 19 included higher fat comparator groups which maintained 
their usual intake, while the low-fat groups underwent interventions with more frequent 
and/or more intense interaction with research staff. Such comparisons do not provide 
evidence to support the effect of the low-fat diets themselves, since the effect of lowering 
total fat intake cannot be distinguished from the other components of the intervention. 
Stratifying by this type of comparator group (Figure 2), it is clear that lowering fat intake 
was not an independent contributor to weight loss. Second, despite concerted efforts among 
motivated clinical trial participants and staff, the average weight loss in all groups after a 
median 1 year of follow-up was a modest 2.7 kg, and 3.8 kg when calculated among weight 
loss trials only.
Our findings contrast with the findings of a previous systematic review and meta-analysis, 
which concluded that reduction in total fat intake leads to clinically meaningful weight loss, 
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reporting 1.57 kg (95% CI=1.97 to 1.16) greater weight loss for low-fat vs. other diet 
interventions.(33) The main differences in their study selection criteria from ours were their 
inclusion of trials with <1 year of follow-up and their deliberate exclusion of trials with any 
weight loss intention. Trials of short duration (e.g. 6 months) are unlikely to demonstrate 
effects representative of long-term effects of diet on weight. Additionally, evaluating low-fat 
diets for weight loss exclusively among trials without a weight loss goal excluded a 
substantial proportion of the available literature, giving a pooled estimate that was over-
weighted by trials comparing low-fat with “usual diet”, as well as trials conducted among 
populations at high risk for specific non-body weight related endpoints of interest (e.g., 
cholesterol-lowering, breast cancer prevention, etc). In our current meta-analysis among 
trials without a weight loss goal and at least 1 year duration, we found that after removing 
comparisons between low-fat and “usual diet”, low-fat interventions did not lead to greater 
weight loss that higher fat interventions (n=7; WMD=0.26 kg, 95% CI=-0.39 to 0.91). In 
fact, of the 33 trials included in their overall analysis, only 8 comparisons were conducted 
among trials giving similar attention to the low-fat and comparator treatment arms, and only 
1 of these lasted at least 1 year. Furthermore, only 3 were among healthy participants. 
Therefore, generalizability of their findings to overall populations intending to lose weight is 
highly questionable, and their estimated effects of reducing fat intake are likely to be 
seriously confounded by differences in comparator group intensity, which was demonstrated 
to be a major source of heterogeneity in our analysis.
Johnston, et al, conducted a network meta-analysis among trials comparing named popular 
diet programs.(34) Pooling both direct (i.e., head-to-head comparison of two interventions 
within a single RCT) and indirect comparison (i.e., non-randomized comparisons of two 
intervention effects derived from separate trials) produced estimates similar to ours, 
indicating significant weight loss at 12 months for low-fat interventions compared with 
“usual diet”, and no significant benefit when compared with other dietary interventions of 
similar intensity. Limitations of indirect comparisons, however, include the inability to 
control for between-study and between-participant differences that may confound the pooled 
estimates. Another recent meta-analysis evaluated 13 trials of low-fat vs. very low-
carbohydrate diet interventions with at least 12 months of follow-up.(35) Their pooled 
estimate indicated a 0.91 kg (95% CI=1.65 to 0.17) greater weight loss for very low-
carbohydrate compared with low-fat diet interventions, consistent with our pooled estimate 
of 1.15 kg for low-carbohydrate vs. low-fat weight loss interventions.
A limitation of this meta-analysis is the substantial heterogeneity within several strata, 
indicating inconsistent effects across studies. Heterogeneity to some degree would be 
expected given the various intervention designs, baseline characteristics of the participants, 
and comparator diets. Stratified analyses reduced heterogeneity in many cases. Additionally, 
our manuscript did not have a pre-published protocol, and our search was limited to English 
language publications, did not include other potential databases, or a search of grey 
literature, which may have missed trials. Finally, the majority of RCTs of ≥1 year duration 
were not feeding trials, since large-scale long-term trials of this nature can be costly; 
therefore, our analysis addresses the effectiveness of dietary interventions, and not 
necessarily the diets themselves.
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The strength of evidence of the literature included in this systematic review is variable with 
a high concern for attrition bias from significant drop-out and loss-to-follow-up rates in the 
majority of trials. Retaining participants for long-term lifestyle interventions can be difficult 
and bias is a concern when attrition is related to intervention assignment. Other bias 
measures were difficult to assess as a whole, without details of methods for randomization 
and allocation concealment, and whether staff members measuring outcomes were blinded.
Findings from our systematic literature review and meta-analysis of RCTs fail to support the 
efficacy of low-fat diet interventions over higher fat diet interventions of similar intensity 
for significant long-term clinically meaningful weight control. Previous trials comparing 
low-fat diet interventions with “usual diet” or minimal intensity control groups have mislead 
perceptions of the efficacy of reductions in fat intake as a strategy for long-term weight loss. 
In fact, comparisons of similar intervention intensity conclude that dietary interventions 
lower in total fat intake lead to significantly less weight loss compared with higher fat, low-
carbohydrate diets. Health and nutrition guidelines should cease recommending low-fat diets 
for weight loss given the clear lack of long-term efficacy over other similar intensity dietary 
interventions. Additional research is needed to identify optimal intervention strategies for 
long-term weight loss and weight maintenance, including the need to look beyond variations 
in macronutrient composition.
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Figure 1. 
PRISMA Flow Diagram
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Figure 2. 
Random effects pooled weighted mean difference (kg) for low-fat vs. comparator dietary 
interventions from 53 randomized trials reporting at least 1 year of follow-up, by weight loss 
intention and comparator intervention.
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Table 2
Random effects pooled weighted mean difference (kg) for low-fat vs. comparator dietary interventions from 
36 randomized weight loss trials reporting at least 1 year of follow-up, stratified by trial characteristics.
N Comparisons WMD (95% CI)
p-
value
I2 (p-value for 
heterogeneity)
Weight Loss Goal
    Similar Intervention Intensity 33 0.62 (−0.08, 1.32) 0.084 71.6% (p<0.0001)
        Comparator Diet
        Low-Carbohydrate 18 1.15 (0.52, 1.79) <0.001 10.4% ( p=0.33)
        Other Higher Fat Intervention 19 0.36 (−0.66, 1.37) 0.49 82.0% (p<0.0001)
        Usual Diet 0 -- --
        Caloric Restriction
        Both Interventions 18 0.74 (−0.19, 1.68) 0.12 78.4% (p <0.0001)
        Neither Intervention 8 0.33 (−1.18, 1.83) 0.67 65.1% (p=0.005)
        Low-Fat Only 6 1.49 (0.53, 2.45) 0.002 7.7% (p=0.37)
        Comparator Only 5 −0.62 (−1.95, 0.72) 0.37 15.5% (p=0.32)
        Chronic Disease Population
        No 25 0.77 (−0.15, 1.69) 0.10 76.1% (p <0.0001)
        Yes 8 0.37 (−0.33, 1.07) 0.30 10.3% (p=0.35)
        Difference in Fat Intake at Follow-up (% Calories)
        <5% Difference in Fat Intake 8 0.14 (−0.80, 1.09) 0.77 30.1% ( p=0.19)
        ≥5% Difference in Fat Intake 18 1.04 (0.06, 2.03) 0.038 77.7% (p<0.0001)
        Difference in Triglycerides at Follow-up (mg/dL 
Change)
        <5 mg/dL Change Difference 8 −0.21 (−0.86, 0.43) 0.52 0.0% (p =0.92)
        ≥5 mg/dL Greater Change in Low-Fat Group 17 1.38 (0.50, 2.25) 0.002 62.3% (p<0.0001)
No Weight Loss Goal
    Similar Intervention Intensity 4 −1.71 (−4.52, 1.10) 0.23 59.3% (p=0.061)
        Comparator Diet
        Low-Carbohydrate 0 -- -- --
        Other Higher Fat Intervention 4 −1.71 (−4.52, 1.10) 0.23 59.3% (p=0.061)
        Usual Diet 0 -- --
        Caloric Restriction
        Both Interventions 0 -- --
        Neither Intervention 2 −1.47 (−5.85, 2.91) 0.51 76.3% (p=0.04)
        Low-Fat Only 0 -- --
        Comparator Only 0 -- --
        Chronic Disease Population
        No 0 -- --
        Yes 4 −1.71 (−4.52, 1.10) 0.23 59.3% (p=0.061)
        Difference in Fat Intake at Follow-up (% Calories)
        <5% Difference in Fat Intake 1 NA NA NA
        ≥5% Difference in Fat Intake 2 −2.18 (−6.19, 1.83) 0.29 45.0% (p=0.18)
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N Comparisons WMD (95% CI)
p-
value
I2 (p-value for 
heterogeneity)
        Difference in Triglycerides at Follow-up (mg/dL 
Change)
        <5 mg/dL Change Difference 1 NA NA NA
        ≥5 mg/dL Greater Change in Low-Fat Group 1 NA NA NA
WMD=DerSimonian and Laird random effects weighted mean difference, in kg; Negative value favors low-fat dietary intervention; Positive value 
favors higher fat comparator intervention
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